CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE

国家卫生研究院（NIH）、尤尼斯·肯尼迪·施莱弗国家儿童健康和人类发展研究所（NICHD）是开展基础临床研究以开发新的避孕药具和评价现有避孕方法和生殖健康的联邦牵头机构。人口研究中心的重要目标是通过使用合同和赠款开发新的避孕药具。在CPR范围内，避孕和生殖健康处（CRHB）长期以来一直支持若干临床前避孕测试设施以及合成化学和合成肽制剂设施。

The National Institutes of Health (NIH), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), is the lead Federal agency for the conduct of basic, clinical research to develop new contraceptives and to evaluate existing methods of contraception and reproductive health. The Center for Population Research (CPR), within NICHD has the important goal of developing new contraceptives through the use of contracts and grants. Within CPR, the Contraception and Reproductive Health Branch (CRHB) has long supported several preclinical contraceptive testing facilities as well as facilities for synthetic chemical and synthetic peptide formulation. With the recompetition of the CCTN, clinical sites will perform Phase I, II, III, and Phase IV clinical trials of a wide variety of new or existing female contraceptive methods. The purpose of this contract is to systematically evaluate the safety and efficacy of new female contraceptive drugs and devices as well as gynecologic conditions, such as endometriosis or leiomyoma, in Phase I, II, III, and IV trials